Malignant melanoma is highly lethal due to its aggressive invasive properties and metastatic dissemination. The transcription factor E2F1 is crucial for melanoma progression through poorly understood mechanisms. Here, we show that the miR-224/miR-452 cluster is significantly increased in advanced melanoma and invasive/ metastatic cell lines that express high levels of E2F1. miR-224/miR-452 expression is directly activated by E2F1 through transactivation of the GABRE gene. Ectopic expression of miR-224/miR-452 in less aggressive cells induces EMT and cytoskeletal rearrangements and enhances migration/invasion. Conversely, miR-224/miR-452 depletion in metastatic cells induces the reversal of EMT, inhibition of motility, loss of the invasive phenotype and an absence of lung metastases in mice. We identify the metastasis suppressor TXNIP as new target of miR-224/miR-452 that induces feedback inhibition of E2F1 and show that miR-224/452-mediated downregulation of TXNIP is essential for E2F1-induced EMT and invasion. The E2F1-miR-224/452-TXNIP axis constitutes a molecular signature that predicts patient survival and may help to set novel therapies.
Introduction
Malignant melanoma as a highly aggressive tumor is characterized by strong metastasis and a pronounced chemoresistance [1, 2] . Reasons for the poor therapeutic suggestibility in advanced stages of this cancer type are defects in apoptotic signaling pathways [2] . Our group has shown first that the E2F1 transcription factor (TF) is key to driving metastasis of melanoma cells [3] . E2F1 acts as tumor suppressor or oncogene [4, 5] . Cellular stress signals, such as uncontrolled cell proliferation and DNA damage, initiate activation of E2F1 as a mediator of apoptosis. However, E2F1 loses its tumor suppressor function in highly aggressive, apoptosis-resistant tumor types like malignant melanoma and contributes to tumor progression [3, 6, 7] .
The exact mechanism of E2F1-induced metastasis is not completely understood. A promising approach to elucidate the molecular issues involved in the acquisition of an enhanced aggressive phenotype essential for E2F1-related tumor progression and metastasis of melanoma is the investigation of dysregulated microRNAs (miRs). MiRs represent a large class of non-protein-coding RNAs, which act as negative gene regulators [8] . They bind their target mRNA sequence either with perfect or imperfect complementary, resulting in RNA degradation or inhibition of translation [8] . Detailed descriptions about miRNA biogenesis and mode of action are given in numerous reviews. According to bioinformatic analysis, each miRNA is able to control hundreds of target mRNAs, allowing this class to manipulate almost every cellular scenario [9] . MiRs are key players in carcinogenesis, as they participate in events that are impaired in cancer, for example proliferation and apoptosis [10] . Since different reports hint toward an interaction of oncogenic miRNAs and E2F1 [11] , an involvement of miRNAs in E2F1-induced cancer metastasis is conceivable. To date, numerous miRs with therapeutic potential have been identified in a variety of tumor types [12] . An interesting example is miR-224, which is well known for its tumorigenic function in hepatocellular carcinoma (HCC) [13] . This miRNA is significantly upregulated during HCC development [14, 15] and contributes to tumor-relevant processes like migration, invasion, proliferation and apoptosis inhibition [13, 16] . In line with these reports, miR-224 is also increased in other tumor types, like clear cell renal cell carcinoma (ccRCC) [17, 18] , colorectal cancer (CRC) [19] [20] [21] and glioma [22] , having an impact on tumor progression. Nevertheless, miR-224 overexpression is also described as an indication for a more favorable prognosis in medullary thyroid carcinoma (MTC) patients, since tumors with high content of miR-224 did not show any node metastases but biochemical healing in posttreatment [23] . Similar findings apply to medulloblastoma, particularly as enhanced miR-224 expression improves responsiveness to radiation and decreases proliferation as well as the transforming capability of medulloblastoma cells [24] . Furthermore, underexpression of miR-224 was identified as a biomarker of oral squamous cell carcinoma (OSCC) [25] . However, apart from the last-mentioned publications, there are considerably more, suggesting a tumorigenic function of miR-224. Interestingly, miR-224 is part of a miRNA cluster [24] . Together with miR-452, it is located intronic in the GABRE gene, which encodes the epsilon subunit of the gamma-aminobutyric acid (GABA) A receptor [24] . In most cases, closely arranged miRs are under the control of common regulatory elements and therefore possess similar biological functions [26] . MiR-452 is dysregulated during diabetic wound healing [27] and decreased upon cigarette smoking in alveolar macrophages [28] . In the course of myoblast differentiation, a reduction of miR-452 was recorded [29] . Furthermore, miR-452 is inhibited by the tumorigenic SOX2 gene in glioblastoma cells [30, 31] and assumed to have a tumorsuppressive potential in medulloblastomas [24] . Intriguingly, miR-452 and miR-452* are described as prognostic markers in urothelial carcinoma, since strong expression of these miRs correlates with the incidence of lymph node metastases and an unfavorable prognosis for patients [32] . MiR-452 was further validated as a urinary marker for bladder cancer determination [33] . Moreover, this miRNA is highly expressed in esophageal cancer tissue [34] , in prostate cancer stem/progenitor cells [35] , as well as in neural crest cells [36] . In the latter, miR-452 was shown to have an influence on an epithelialmesenchymal signaling pathway in the first pharyngeal arch [36] .
Regarding putative oncogenic activities of miR-224 in various malignancies and first hints about overexpression of miR-452 in some kinds of human cancer, we investigated the role of the whole cluster in melanoma progression. Here, we show that expression of miR-224/452 in invasive/metastatic melanoma is controlled by E2F1 causing a decrease of the metastasis suppressor TXNIP that blocks E2F1 in a regulatory loop. Our results demonstrate a novel transcription factor (E2F1)-miRNA axis that is activated during melanoma progression and promotes reversible phenotypic changes toward epithelial-mesenchymal transition (EMT) and invasion.
Results

E2F1 induces miR-224/452 expression during melanoma development
First, we analyzed the expression levels of potentially oncogenic miRs in primary and metastatic patient samples and found a high content of miR-224 and miR-452 in the latter (Fig 1A, upper panel) . These results were confirmed in established clinically relevant melanoma cell systems including SK-Mel-28, SK-Mel-29, SK-Mel-103 and SK-Mel-147 ( Fig 1A, lower panel) . As described by Alla et al [3] , the behavior of non-invasive SK-Mel-28/SK-Mel-29 and invasive/metastatic SK-Mel-103/SK-Mel-147 cells that correspond to primary tumors and metastases with low or high E2F1 expression, respectively, is clearly E2F1 dependent and thus represents an optimal model system to study the interaction between the transcription factor and the identified miRs.
Since miR-224/452 expression correlates with E2F1 levels in primary versus metastatic patient samples as well as in invasive versus non-invasive melanoma cells, regulation of miR-224/452 by E2F1 is conceivable (Fig 1A) . In order to verify the effect of E2F1 on miR expression, SK-Mel-29.ER-E2F1 cells stably expressing E2F1 fused to the ligand-binding domain of the murine estrogen receptor (ER) were treated with tamoxifen (4-OHT). In parallel, we examined miR-224/452 expression in invasive/metastatic SK-Mel-147 cells after E2F1 knockdown using lentiviral pLKO.1-shE2F1 that ensures efficient depletion of E2F1 in melanoma cells. E2F1 activation and knockdown was confirmed by detection of the E2F1 target survivin. As shown in Fig 1B, the miR-224/452 cluster is strongly upregulated upon E2F1 activation in SK-Mel-29.ER-E2F1 cells compared to parental SK-Mel-29, whereas knockdown of the transcription factor in SK-Mel-147 cells led to decreased expression of both miRs.
MiRNAs are located inside or outside of genes. Intergenic miRs are produced from their own transcriptional units. In contrast, miRNAs in introns of protein-coding genes are usually regulated by the gene promoter and processed with the precursor mRNA. This often results in co-expression of miR and host gene [37] . Since miR-224 and miR-452 are located in the gamma-aminobutyric acid (GABA) A receptor epsilon gene (GABRE), we examined whether this gene is regulated through E2F1 (Fig 1C) . GABRE protein expression clearly correlates with the level of E2F1 in SK-Mel-103 and SKMel-147 cells (Fig 1C, top panel) showing elevated miR-224/452 levels ( Fig 1A) . Furthermore, decreased expression of the host gene after E2F1 ablation in invasive/metastatic SK-Mel-147 and upregulation of GABRE upon E2F1 activation in non-metastatic SK-Mel-29.ER-E2F1 indicates its transcriptional co-regulation with miR-224/ 452 by E2F1 (Fig 1C, lower panel) . In silico analysis of putative transcription factor binding sites in the GABRE promoter revealed three E2F elements in the region 812 bp upstream of the transcriptional start site ; GABRE 2 -358-391 containing 2 E2F-motifs), which were confirmed using chromatin immunoprecipitation (ChIP) (Fig 1D) . To verify transcriptional activation by E2F1, the GABRE promoter region was cloned into the pGL3-basic reporter plasmid. Luciferase assay revealed a clear induction under E2F1 co-transfection in a concentration-dependent manner, whereas E2F1-mutants E(-TA) and E123 did not stimulate the promoter (Fig 1E) . Thus, in advanced tumors with high levels of E2F1, the transcription factor leads to the induction of miR-224/452 by transactivating their host gene GABRE.
MiR-224/452 cluster is an essential mediator of EMT and melanoma invasion
According to the cellular context, miR-224 and miR-452 show oncogenic as well as tumor suppressive properties. Therefore, functional analysis of the entire cluster is required to clearly assign potential cancer-promoting effects to one specific miR or the cooperation of both. To this end, we constructed lentiviral vectors for efficient and stable expression of individual candidates or the entire cluster in SK-Mel-29 (Fig 2) and SK-Mel-28 cells (Supplementary Fig S2) . Functional assays were performed in comparison with parental control cell lines expressing a randomly generated scrambled sequence (Scr). MiR expression levels were validated by TaqManMicroRNA single assays (Fig 2A) . Stable expression of miR-224/452 in non-invasive SK-Mel-29 resulted in increased migration and invasion (Fig 2B and C ; Supplementary Fig S1A and B) . The same effect was observed in miR-expressing SK-Mel-28 cells (Supplementary Fig S2) . In addition, we analyzed the impact of miR-224/452 on epithelial-mesenchymal transition, a highly conserved genetic program that enables epithelial tumor cells to migrate from the existing cell layer into surrounding tissues. This process includes loss of intercellular tight junctions and cell polarity, and the acquisition of mesenchymal properties [38] [39] [40] . As reported previously, knockdown of endogenous E2F1 in metastatic melanoma cells restored expression of the epithelial marker E-cadherin [3] . In accordance, non-invasive SK-Mel-29 cells that stably express miR-224/452 show loss of E-cadherin. These cells attain a mesenchymal state associated with increased levels of Slug, ZEB1 and vimentin that are substantially upregulated through miR-224 and/or miR-452 overexpression, whereas ZEB2, shown to be a differentiation factor in melanoma [41] , is downregulated ( Fig 2D) . Furthermore, the miR-224/452 cluster induces changes in the actin cytoskeleton toward a more aggressive phenotype as evident from phalloidin/ TRITC staining ( Fig 2E) .
To directly assess the activity of endogenous miR-224/452 on the migratory/invasive capacity in the presence of high E2F1 levels, SK-Mel-147 cells were stably transduced with lentiviral vectors encoding shRNAs against miR-224 (miRZIP-224) and miR-452 (miR-ZIP-452) to specifically ablate miRNA expression. Efficient knockdown of miR-224/452 expression is shown in Fig 3A . Supplementary Fig S3A) and migrate across the scratched area ( Fig 3C) was markedly reduced. A significantly impaired motility under miRZIP-224/452 expression was also observed in aggressive SK-Mel-103 cells ( Supplementary Fig S4) . Similar to miR-224/452 overexpression studies in SK-Mel-29, the strongest effect was achieved by the ablation of both miRs. In addition, knockdown of miR-224/452 in SK-Mel-147 caused an increase of epithelial E-cadherin and ZEB2, whereas mesenchymal vimentin, ZEB1 and Slug decreased compared to miRZIP-Scr control cells (Fig 3D) . Upregulation of E-cadherin and downregulation of vimentin as key epithelial and mesenchymal markers was also confirmed in miR-224/452-depleted SK-Mel-147 cells by immunofluorescence staining (Fig 3E) . These miR-224/452 knockdown cells showed clear changes in the actin cytoskeleton toward a less aggressive phenotype ( Fig 3E, lower panel). Whereas parental control cells exhibit actin-bearing membrane ruffles and thin F-actin filaments oriented parallel to the major cell axis as a typical feature of migrating cells, such characteristic structures are not visible after depletion of miR-224/452. Moreover, miR-depleted cells displayed actin staining predominantly at cell-cell contacts suggesting stronger cell-cell adhesions and impaired motility [42] . Finally, in compliance with these morphological changes and the impaired migration/invasion, aggressive melanoma cells completely failed to form metastases in vivo when miR-224/452 expression is blocked (Fig 3F) . Notably, while invasive growth is largely abrogated after E2F1 depletion in SK-Mel-147.miR-Scr cells, those cells in which miR-224, miR-452 or both are re-expressed retain their aggressive behavior also in the absence of E2F1 (Fig 3G; Supplementary Fig S3B) , pointing out their autonomous oncogenic capabilities. The expression levels of miR-224/452 are shown in Supplementary Fig S3C. MiR-224/452 regulates metastasis suppressor TXNIP
To further investigate the mechanism by which miR-224/452 promotes tumor progression, we analyzed putative targets of this cluster (Fig 4A) . In order to identify shared target genes of miR-224 and miR-452, we extracted from the starBase database (v1.0) [43] Argonaute-target interaction sites that match computationally predicted target sites of one of the two miRNAs. The data in starBase are derived from high-throughput CLIP-Seq experiments. Those targets in which binding sites for both miRNAs exist were considered for further analysis. Furthermore, we extracted predicted mutual targets of both miRNAs from the miRror Suite [44] , a Web service that integrates predictions from twelve complementary algorithms and computes targets that are regulated by a set of miRNAs in a coordinated fashion. From these targets, we considered only those with approved AGO binding sites based on starBase. In total, we received a set of 20 target genes (Supplementary Table S1 ) most likely being targeted by both miR-224 and miR-452. From this set, we selected those genes with relevance in cancer based on their associated Gene Ontology terms [45] . After GO filtering, a set of targets were subjected for experimental validation (Fig 4A) . The most notable one was thioredoxin-interacting protein TXNIP (also named as VDUP-1 or TBP-2), which is often downregulated in cancer and known as a proapoptotic factor and metastasis suppressor [46, 47] . Validation experiments revealed a clear inhibition of TXNIP upon miR-224 and miR-452 overexpression in SK-Mel-29, and its upregulation under knockdown of these miRs in metastatic SK-Mel-147 both on RNA (Fig 4B, upper panel) and protein level (Fig 4B, lower panel) . Consistent with our data demonstrating that miR-224 and miR-452 are regulated by E2F1, knockdown of the transcription factor resulted in an increase of TXNIP, whereas target level declined in response to E2F1 activation through 4OHT addition (Fig 4C) . Furthermore, luciferase activity of the pMiR-Report construct containing the 3 0 UTR of TXNIP was vigorously reduced after miR-224 and/or miR-452 co-transfection in SK-Mel-29 cells (Fig 4D, left panel) . In addition, we transfected pMiR-Report-TXNIP-3 0 UTR together with miRZIP plasmids against miR-224/452 in SK- 
Loss of TXNIP promotes EMT and invasion by the E2F1-miR-224/ 452 axis
Based on the results that TXNIP is a target of miR-224/452 and their function in melanoma progression, we speculated whether this oncogenic behavior is dependent on TXNIP inhibition. For this purpose, we expressed TXNIP (without 3 0 UTR) in metastatic melanoma cells with low endogenous levels of this protein and analyzed changes in invasion and migration. Indeed, similar to the ablation of miR-224/452, overexpression of TXNIP in SK-Mel-147 led to an efficient reduction of migrating/invading cells (Fig 5A and B ; Supplementary Fig S6A and B) . Furthermore, Western blot analysis indicated a gain of E-cadherin expression and loss of mesenchymal markers at levels comparable to miR-224/452-depleted cells (Fig 5C) . The effect of TXNIP on melanoma cell invasion became even more apparent in miR-224/miR-452-positive SK-Mel-29 cells, which showed enhanced migratory properties (Fig 2) . Ectopic overexpression of TXNIP in these cells suppressed miR-224/452-mediated invasiveness to the level detected for SK-Mel-29.miR-Scr control cells (Fig 5D; Supplementary Fig S6C) . Importantly, increased invasion of less aggressive melanoma cells by overexpression of E2F1 was significantly reduced upon knockdown of miR-224 and miR-452. As demonstrated in Fig 6A and Supplementary Fig S7A, this is due to the recovery of TXNIP expression upon miR-224/452 inhibition. In support of the relevance of TXNIP downregulation during E2F1-miR-224/452-induced malignant progression, E2F1-induced invasion of SK-Mel-29 cells is also markedly reduced when TXNIP (without 3 0 UTR) is re-expressed (Fig 6B, left; Supplementary Fig S7B) . Moreover, depletion of endogenously high E2F1 in SK-Mel-147 cells which is associated with the upregulation of TXNIP protein expression (Fig 6B, right) severely reduced their invasive capacity, whereas knockdown of TXNIP in these cells is needed to increase invasivity again (Fig 6B, right; Supplementary Fig S7B) . Similar effects 
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were observed for the E2F1-mediated EMT phenotype where the E2F1-induced decrease of E-cadherin and increase of mesenchymal markers was to some extend reversed through re-expression of TXNIP (Fig 6C, left) . Furthermore, gain of epithelial and loss of mesenchymal markers in SK-Mel-147 cells ablated for E2F1 was to a significant part recovered by shTXNIP treatment (Fig 6C, right) . Hence, loss of TXNIP in melanoma cells due to aberrant E2F1-miR-224/452 expression is crucial for the transcription factor to induce cancer progression. Based on these findings, we compared the expression levels of E2F1 and TXNIP in vivo at the stages of melanoma progression where an EMT-like switch takes place, namely at the invasive front of primary melanomas, when they colonize the underlying dermis using expression data from a melanoma study (Xu et al 2008) available at Oncomine TM database (Compendia Bioscience, Ann Arbor, MI) [48] and own human samples of different Breslow depth. As shown in Fig 7A, E2F1 levels positively correlate with Breslow depth of primary tumors (> 4 mm, high E2F1 expression versus < 1 mm, low E2F1 expression, P < 0.0053). Conversely, TXNIP expression and Breslow depth of invasion show an inverse correlation with low TXNIP levels at > 4 mm versus high levels at < 1 mm depth of invasion (P < 0.0039). This was confirmed by RT-PCR (Fig 7B) and immunohistochemical analysis (Fig 7C) in a statistically significant number of own primary patient tumors with low versus high Breslow Index. These data, clearly indicating a statistically significant association between high E2F1 versus low TXNIP expression and the highest invasion depth of primary melanoma predictive for progression and severity of the disease, again underscore the relevance of the uncovered E2F1-miR-224/452-TXNIP axis and support that the components of this module can serve as novel prognostic markers for melanoma patients at an early stage of metastasis initiation.
E2F1 and TXNIP contribute to cancer progression in a regulatory feedback loop
Previously, TXNIP has been implicated in growth suppression in association with an increase of p16 expression and reduction of retinoblastoma (RB) phosphorylation [49] . Since hypophosphorylated RB leads to the inhibition of E2F1 function, we suspected a mutual regulation of TXNIP and E2F1 to avoid uncontrolled E2F1 activity by building a negative feedback loop. Immunoblotting demonstrated a reduced expression of E2F1 in SK-Mel-103/-147 cells after TXNIP overexpression (Fig 7D) . To identify the possible mechanism for the TXNIP-induced decrease of E2F1, we tested its influence on different regulators of E2F1 activity. In accordance with the observations made by Nishinaka et al, p16 increased and phospho-RB decreased through TXNIP also in melanoma cells. The CDK inhibitor p16 inhibits different cyclin-dependent kinases, which are able to phosphorylate RB. We found that CDK4 was strongly downregulated under these circumstances (Fig 7D) . This argues that TXNIP indeed provides a negative feedback loop that prevents excessive E2F1 activity. In line with elevated levels of CDK4, hyperphosphorylation of RB and consecutive stimulation of E2F1 in both aggressive melanoma cell lines, miR-224/452 potentiates the accumulation of E2F1 by inhibiting TXNIP, which contributes to skin cancer progression (Fig 7E) . This finding hints toward a putative therapeutic approach to avoid EMT of tumor cells either by knockdown of miR-224/452 or addition of TXNIP.
Discussion
E2F1 is a critical factor for metastasis in melanoma. Since the exact mechanisms are incompletely understood, we investigated the role of miRs in E2F1-induced tumor progression. There are several reports on miRs regulating this transcription factor, but except some hints, it was less known about E2F1-induced miRs. Here, we uncovered the importance of E2F1-induced miRs for its oncogenic activity in melanoma progression. We could show that the miR-224/miR-452 cluster is upregulated in invasive/metastatic melanoma and controls as part of a gene regulatory module the stage of melanoma progression where an EMT-like switch takes place. The results demonstrate that expression of miR-224/miR-452 is necessary and sufficient to elicit an EMT phenotype and that this process is induced by the E2F1 TF via direct activation of the GABRE host gene and its intronic miRs. Increased miR-224/452 promotes oncogenic transition into a metastatic state by repressing the metastasis suppressor TXNIP. Interestingly, this factor in turn controls E2F1 activity in a negative regulatory loop.
As yet, there are only few studies on the whole cluster describing a correlation in miR-224/452 and GABRE expression, such as two recent publications on concomitant regulation of miR-224/452 and GABRE by epigenetic mechanisms, resulting in either high expression in HCC patients or low expression in prostate cancer [50, 51] . These findings already reflect the ability of both miRs to act as tumor suppressor or oncogene in a cell-context-dependent manner. In the present study, functional analyses on miR-224/452 clearly As re-introduction of these miRs after E2F1 ablation in invasive/metastatic melanoma cells could recover their oncogenic effects, they are able to act independently of the transcription factor. The epithelial-mesenchymal transition is an important prerequisite for metastatic cancer. As a process of epithelial plasticity, it includes dissolution of epithelial cell-cell adhesions, actin cytoskeleton reorganization, as well as an increase in cell-matrix contacts, leading to enhanced migration and invasion [42] . It is well known that miRs are able to influence EMT [52] . One of the first and well-described examples is the regulation of ZEB proteins by miR-205 as well as the miR-200 family. Inhibition of the E-cadherin repressors ZEB1 and ZEB2 by these miRs results in the stabilization of an epithelial phenotype of cancer cells [53] [54] [55] . Concerning a putative role of miR-224/452 on EMT, there are only limited and controversial reports by Zhang et al [13] who found an increase of E-cadherin in miR-224-depleted Huh-7 cells, whereas miR-224 has been shown to correlate with high E-cadherin expression in normal breast epithelium [56] . In addition, miR-452 is known to be highly expressed in neural crest cells having an influence on an epithelialmesenchymal signaling pathway in the first pharyngeal arch [36] . In our study, ectopic miR-224/452 mediates the EMT-like phenotype in non-invasive melanoma cells through increased expression of the transcription factors Slug and ZEB1, which are known repressors of epithelial E-cadherin [57] . In line with E-cadherin decrease, the intermediate filament protein vimentin as mesenchymal marker that promotes cell migration and invasion is upregulated [58] . The reverse effect on these EMT markers was observed when both miRs were knocked down in metastatic tumor cells. Consistent with previous studies indicating that remodeling of actin filaments is essential for EMT as it promotes cell migration and metastatic spread from primary tumors [42] , we have shown that E2F1-miR-224/452-induced EMT involves cytoskeletal changes toward an aggressive cancer phenotype.
We uncovered TXNIP as an important target of both miRs. TXNIP was initially identified as thioredoxin-binding protein that inhibits thioredoxin (TRX), thereby contributing to redox homeostasis [59] . Since TRX also promotes tumor progression by angiogenesis induction [60] and apoptosis inhibition [61, 62] hepatocellular carcinoma (HCC), and breast and bladder cancer emphasize its relevance for tumor prevention, since less TXNIP expression clearly contributes to cancer malignancy [63] [64] [65] [66] [67] . Interestingly, TXNIP is also described as a metastasis suppressor, which leads to less lung metastases in mice after overexpression in aggressive melanoma cells [47] . In accordance with these findings, knockdown of miR-224/452 results in enhanced TXNIP expression, reduced migration and invasion, and the absence of metastases formation in vivo. Goldberg et al [47] detected low TXNIP expression in metastatic melanoma cells as a reason of Chr6 deletion. TXNIP itself is not located on Chr6; however, relevant regulators of this protein originate from Chr6, like CRSP3. In this regard, our data provide another way of TXNIP inhibition via E2F1-mediated miR-224/452 expression that is clearly important in melanoma cells without chromosome 6 deletion and supports the impact of silencing TXNIP to facilitate malignant progression. This is the case for SK-Mel-28/-29/-103 and -147 used in this study, which have apparently no Chr6 deletion as TXNIP is still expressed in SK-Mel-29 cells and can be recovered by inhibition of the E2F1-miR-224/452 module in SK-Mel-147 cells. In addition, we detected CRSP3 as a gene, which is located on Chr6 in these melanoma cell lines (data not shown). However, miR-224/452 induction by E2F1 is also essential in cells having such a modification, since TXNIP is still expressed and might be active at a certain threshold [47] . Thus, the E2F1-miR-224/452-TXNIP axis represents a key regulatory mechanism to force tumor progression. According to the role of miR-224/452 in an E2F1-induced EMTlike program, downregulation of its target TXNIP in non-invasive SK-Mel-29 cells upon E2F1 induction showed identical effects with an increase of mesenchymal and decrease of epithelial markers as described above. However, re-introduction of TXNIP rescued these effects to an incomplete but considerable extend, resulting in mesenchymal-epithelial transition and inhibition of invasion. In contrast, knockdown of E2F1 in highly aggressive melanoma cells leads to the induction of TXNIP and a more epithelial phenotype (gain of E-cadherin and loss of Slug, ZEB1 and vimentin). This process is partially reversible after ablation of the metastasis suppressor and shows that the removal of TXNIP during E2F1-induced melanoma progression is absolutely critical for the transcription factor to promote an EMT-like phenotype. The new E2F1 activity is also reflected by an inverse correlation between high E2F1 and low TXNIP expression in primary melanoma samples from patients with more than 4 mm Breslow depth of invasion compared to noninvasive tumor states. A previous study by Masaki et al [68] reported that loss of TXNIP enhances TGF-b-induced EMT, and this was associated with loss of E-cadherin and a gain of Slug and vimentin. In contrast, impaired TGF-b-mediated EMT has been detected in TXNIP-ablated cells in the context of diabetic nephropathy [69] . These contradictory observations may result from the different cellular systems, which means breast and lung cancer cell lines versus proximal tubular cells derived from normal kidney. Thus, E2F1-induced oncogenic EMT bears some similarity with the signaling of the well-known EMT inducer TGF-b in cancer cells. As an inhibitor of the antioxidant protein TRX, overexpression of TXNIP in vitro increases the production of reactive oxygen species (ROS) and induces oxidative stress [70] . Although ROS have controversial roles in tumorigenesis by inducing DNA mutations, genomic instability and aberrant pro-tumorigenic signaling on the one hand, as well as being toxic to cancer cells through the induction of cell death [71] , oxidative stress apparently plays no role in mediating miR-224/452-induced tumor cell EMT and invasion. TXNIP has also critical functions in regulating glucose homeostasis, linking loss of TXNIP to the Warburg cancer phenotype. However, there was no evidence that supported a connection between TXNIP Susanne Knoll et al E2F1-miR-224/452-TXNIP axis promotes EMT EMBO reports and metabolism through increased redox stress, suggesting that TXNIP does not act primarily as an inhibitor of thioredoxin [72] . Given that miR-224/452-mediated TXNIP repression, which should reduce oxidative stress, drives EMT, the obvious implication here is that metastasis suppression by TXNIP similar to its metabolic function does not occur via TRX/ROS regulation. This view is also underscored by the finding that TXNIP depletion in the context of TGF-b-induced EMT did not result in altered TRX levels [68] . Strikingly, we observed that high levels of TXNIP cause a decrease of E2F1 expression. In order to elucidate the mechanism behind it, we investigated different upstream regulators of E2F1. In accordance with Nishinaka and colleagues who showed that TXNIP induces p16 resulting in reduced phospho-RB levels in HTLV-I positive T cells [49] , the same effect on p16 and RB together with decreasing expression of cyclin-dependent kinase 4 was seen in melanoma cells. Hence, TXNIP is able to inhibit E2F1 via the p16/ CDK4/RB axis. This interesting finding gives strong support that E2F1 and TXNIP are integral part of a regulatory loop in which increasingly high levels of E2F1 during cancer progression promote an EMT-like switch by miR-224/452-mediated repression of TXNIP, whereas high TXNIP expression in early primary tumors initially restricts malignant progression by inhibiting E2F1 (Fig 7E) .
In sum, our results demonstrate that E2F1 is a new EMTpromoting transcription factor. The miR-224/452 cluster represents a key mediator of E2F1-induced tumor progression, since it inhibits the metastasis suppressor TXNIP and contributes to EMT, invasion/ migration and metastatic spread of melanoma cells. The uncovered mutual regulation between E2F1 and TXNIP points toward new prognostic and therapeutic options by using components of the E2F1-miR-224/452-TXNIP axis as potential key targets to restrict cancer progression.
Materials and Methods
Cell culture and lentiviral transduction
Melanoma cell lines SK-Mel-28, SK-Mel-29, SK-Mel-103 and SK-Mel-147 were maintained in Dulbecco's modified Eagle medium (high glucose, 4.5 g/l) containing sodium pyruvate as previously described [3] . For E2F1 induction in SK-Mel-29.ER-E2F1 cells, 1 lM of 4-hydroxytamoxifen (4-OHT) was used [3] . Stable cell lines expressing either miRNAs or anti-microRNAs were obtained by lentiviral transduction. Virus particle production required co-transfection of the expression plasmids, psPAX2 ('packaging') and pMD2.G vector ('envelope') in HEK 293T cells [73] . In general, large and small RNA was extracted using the NucleoSpin miRNA kit (MACHEREY-NAGEL). MicroRNA expression levels were measured using TaqManMicroRNA single assays and the 7900HT Fast Real-Time PCR System (Applied Biosystems). For expression analysis, the comparative C T method was used with RNU6B as endogenous control [73] . For semiquantitative PCR, 1 lg of RNA was reverse transcribed using First Strand cDNA Synthesis Kit (Thermo Scientific). cDNA was added to Thermo Scientific PCR Master Mix (2×) and amplified with specific primers in a MyCycler Thermal Cycler (Bio-Rad). Actin was used as a loading control. For qRT-PCR, cDNA was added to iQTM SYBR Green Supermix and analyzed using iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad). Relative gene expression was calculated by the comparative C T method using actin for normalization. For primer sequences, see Supplementary Table S2 .
Western blotting and immunofluorescence
Protein analysis was performed as described previously [74] . Briefly, cell lysis was carried out using RIPA buffer, containing PhosSTOP Phosphatase Inhibitor Cocktail (Roche), and protein concentration was determined by Bradford assay (Bio-Rad). The same quantity of different protein samples was separated by SDS-PAGE and transferred to nitrocellulose membranes (Amersham Biosciences) [74] . Selected proteins were detected by the use of specific antibodies for E2F1 (KH-95, BD Biosciences), E-cadherin (Cell Signaling, BD), vimentin (V9, Santa Cruz), ZEB1 (H-102, Santa Cruz), Slug (H-140, Santa Cruz), GABRE (H-110, Santa Cruz), CDK4 (C-22, Santa Cruz), RB-P (Cell Signaling), survivin (Abcam), E2F1 (BD), TXNIP (K0205-3, MBL), p16 (M-156, Santa Cruz), ZEB2 (Sigma) and actin (Sigma) and their corresponding HRP-conjugated secondary antibodies. ECL Plus Western Blotting Detection Reagents (GE Healthcare) allowed detection of HRP activity with X-ray films.
For immunofluorescence, cells were grown on coverslips, fixed with 4% paraformaldehyde, permeabilized with Triton X-100 and blocked with bovine serum albumin (BSA). Incubation with primary antibodies was performed overnight. For visualization with the inverted confocal laser scanning microscope (Zeiss, ELYRA PS.1), fluorescence-labeled secondary antibodies (Cy3, Cy5; Molecular Probes) were used [74] . Cytoskeleton staining was determined by Phalloidin/TRITC staining.
Chromatin immunoprecipitation (ChIP)
ChIP assay was carried out essentially as described [75] using SKMel-29.ER-E2F1 cells.
Cloning of expression plasmids and 3
0 UTRs constructs and luciferase reporter assay
MiRNAs hsa-miR-224, hsa-miR-452, GABRE promoter and TXNIP 3 0 UTR were amplified by PCR using genomic DNA as template and cloned into the pWPXL-, pGL3-basic-and pMiR-Report-vector. TXNIP was amplified from cDNA and cloned into pWPXL-expression vector. For primer sequences, see Supplementary Table S2 . For luciferase assays, cells were transfected using Turbofect (Thermo Scientific). MiR knockdown was achieved with commercially available miRZip TM vectors (SBI System Biosciences). Luciferase activity was measured 36 h after transfection using the Luciferase Reporter Assay System (Promega) and normalized to total protein concentration in cell extract [73] .
Animal studies and histological analysis 2 × 10 6 tumor cells stably expressing miRZIP-Scr or miRZIP-224/ 452 were injected into the tail vein of athymic NMRI nude mice at the age of 6 to 8 weeks (Charles River). Mice were monitored for lung metastases over several weeks. Lung tissue was surgically excised, fixed in 4% paraformaldehyde, paraffin-embedded and processed for histological analysis with hematoxylin and eosin staining. All animal experiments were performed according to the Institutional Animal Care and Use Committee.
Boyden chamber and scratch assays
For Boyden chamber assay, cells were seeded on a 8-lm PET membrane (BD BioCoat TM BD Matrigel TM Invasion Chamber, 6-well) covered with BD Matrigel TM Basement Membrane Matrix (BD Bioscience). A concentration gradient between media in cell culture inserts and surrounding well caused cell invasion through the pores of the membrane. Finally, cells of the upper membrane surface were detached, whereas the ones of the lower surface were stained with DAPI and documented by fluorescence microscopy. Wound healing assay (scratch assay) was performed with Ibidi's culture inserts that allow creating a defined gap of 500 lm between two areas with the same amount of confluent cells. Cell migration was determined by the extent of the gap closure, which was documented by microscopy recordings at certain times.
Human melanoma tissues and immunohistochemistry
For molecular analysis, primary melanoma and melanoma metastases were investigated by real-time RT-PCR and immunohistochemistry. This study was approved by the Ethics Committees of the Universities of Rostock and Kiel, Germany, and informed consent was obtained from all subjects.
Formaldehyde-fixed paraffin-embedded (FFPE) primary melanomas with different Breslow Index were immunohistologically analyzed. 4-lm-thick slices were cut and for heat-induced epitope retrieval pretreated with Tris/EDTA buffer pH 9.0. Tissue slides were blocked with BSA and incubated overnight using the following antibodies and dilutions: TXNIP (1:50, K0205-3, MBL) and E2F1 (1:50, KH-95, Santa Cruz). Finally, slides were washed and developed using LSAB+ System-HRP (Dako) and microscopically analyzed.
Identification of miR-224/452 candidate targets using bioinformatic tools
We extracted from the starBase database (v1.0) [43] Argonautetarget interaction sites that match computationally predicted target sites of miR-224 or miR-452. Those targets in which binding sites for both miRNAs exist where considered for further analysis. Furthermore, we retrieved predicted targets that are shared by both miRNAs from the miRror Suite [44] . From these targets, we considered only those with approved AGO binding sites based on starBase. In total, we received a set of 20 target genes. From this set, we selected those genes with relevance in cancer based on their associated Gene Ontology terms [45] (Fig 4A; Supplementary  Table S1 ).
Statistical analysis
P-values were calculated using the Student's t-test or WilcoxonMann-Whitney (Mann-Whitney) U-test as indicated. All bar graphs are plotted as mean AE SD. Box-whisker plots indicate the 25 and 75% quartile surrounding the median and the minimum and maximum as well as outliers. Statistical significance: n.s., no significance, *P ≤ 0.05; **P ≤ 0.01. Statistical significance was calculated using the R software package (http://www.r-project.org).
Supplementary information for this article is available online:
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